Navigation Links
Kensey Nash Announces Exclusive License of Optical Guidance Patent to Enhance Chronic Total Occlusion Platform
Date:11/2/2007

EXTON, Pa., Nov. 2 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (Nasdaq: KNSY) today announced that it has exclusively licensed U.S. patent 6,175,669, Optical Coherence Domain Reflectometry Guidewire, from Lawrence Livermore National Security, LLC to further expand the intellectual property portfolio related to its chronic total occlusion (CTO) platform. The patent covers a guidewire with enhanced optical sensing capabilities, allowing it to sense locations, thickness, and structure of the arterial walls as it navigates through the body. The concept and technology, which are complimentary to Kensey Nash's Safe-Cross(R) RF CTO System, will allow the Company to develop next generation CTO devices with enhanced guidance and revascularization capabilities. The Safe-Cross System uses a forward-looking guidance system and radio frequency (RF) energy to safely cross and recanalize chronic total occlusions in the coronary and peripheral arteries. The terms of the license were not disclosed.

At the TransCatheter Therapeutics Conference (TCT) in Washington, D.C. last week, Dr. Charles Simonton, Carolinas Medical Center, performed a live case demonstrating the utility of the Safe-Cross System in crossing an in-stent restenosis CTO, greater than six months in age, in a patient's left anterior descending (LAD) coronary artery. The total crossing time was about fifteen minutes. Commenting on the Safe-Cross System and Kensey Nash's development plans for its platform, Dr. Simonton said, "The Safe-Cross System is unique as the only device for CTO lesions that incorporates optical feedback to provide guidance and radio frequency energy to penetrate difficult coronary occlusions. I am very pleased that Kensey Nash will be ref
'/>"/>

SOURCE Kensey Nash Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... Evaluation and treatment cli... Woodstock (Vocus) November 25, 2009 -- Cen...sal vaccines and H1N1 vaccine shots at four Centeg...other shipment of vaccine has arrived. The clinics...ake and McHenry and will be open as follows: , ...
(Date:11/25/2009)...ore positive note, CDC sees few signs of trouble w...v. 25 (HealthDay News) -- The ongoing H1N1 swine f...rous pneumonias among younger patients, a U.S. hea...n increase in serious pneumococcal infections arou...e National Center for Immunization and Respiratory...
(Date:11/25/2009)..., LittleImprovementShownforthe4thStraightYear ... Today,LungCancerAlliance-Georgia(LCA-GA)issuedth...ssessmentofprogressbeingmadeagainstthislethaldisea...Alliance(LCA),theonlynationalorganizationdedicated...ingwithoratriskforlungcancer. ,, (Logo: http://...
(Date:11/25/2009)...e serious behavior problems that can occur in chil...uced with a treatment plan that includes medicatio...parents, according to Yale University researchers ...er 2009 issue of the Journal of the American Acad... was conducted by the National Institute of Mental...
(Date:11/25/2009)... Nationwide Imaging Services,...anizations for diagnostic imaging equipment, now o... including financing options, service and installa... Atlas Medical Technologies of California) , ... 2009 -- Nationwide Imaging Services is proud to a...
Breaking Medicine News(10 mins):Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2Health News:Parent training key to improved treatment of behavior problems in children with autism 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 3
...ON, Wis., April 7, 2008 Each year cancer touches,...n the United States than,any other disease. At 6:0...nt in Middleton, Wisconsin will see over 38 people...adise, 1601 Aspen,Commons in Greenway Station, to ...
... to Support the Solutions for Intelligence Analysi...08 ,Science Applications International Corporation...ime contract in December by the Defense Intelligen...ram. The maximum dollar value for all task orders ...
... Mass., April 7, 2008 Boston,Scientific Corporati...f,Timothy Pratt as its new General Counsel. Pratt ...ical device and pharmaceutical litigation. He,will...o President and Chief Executive Officer Jim Tobin....
...se of tobacco, alcohol, drugs may affect kids into..., April 7 (HealthDay News) -- Babies born to women...ncy may have brain structure changes that persist ...rains of 35 children, average age 12, who were exp...
...uggests a link between less drug therapy and more ...ealthDay News) -- In 2004, Medicare reduced its re...prostate cancer by blocking the activity of male h...udy found. , It,s not possible to say that financi...
...LE, Tenn., April 7, 2008 Pet DRx,Corporation ("Pe...), a,provider of veterinary primary care and speci...ed its financial results for the year ended Decemb...year ended December 2006. The nearly four-fo...
Other Medicine News:Health News:What Would You Look Like Bald? Like a Hero to Kids With Cancer, Says the St. Baldrick's Foundation 2Health News:SAIC Awarded DIA Intelligence Analysis Contract 2Health News:Boston Scientific Announces Appointment of Timothy Pratt as General Counsel 2Health News:Boston Scientific Announces Appointment of Timothy Pratt as General Counsel 3Health News:Fetal Exposure to Substance Abuse Changes Brain Structure 2Health News:Did Medicare Reimbursement Changes Affect Prostate Cancer Treatment? 2Health News:Did Medicare Reimbursement Changes Affect Prostate Cancer Treatment? 3Health News:Pet DRx Corporation Reports 2007 Financial Results 2Health News:Pet DRx Corporation Reports 2007 Financial Results 3Health News:Pet DRx Corporation Reports 2007 Financial Results 4
(Date:11/24/2009)...d.,Nov.24/PRNewswire-Asia/--ChindexInternational,I...AmericanproviderofWestern,healthcareproductsandser...hattheCompanywillattendthe21stAnnualPiperJaffray,"...,2009,atthe,NewYorkPalaceHotel. , Managementi...December1,2009,andholdone-on-onemeetingsthroughout...
(Date:11/24/2009)...J.,Nov.24/PRNewswire-FirstCall/--QuestDiagnosticsI...fdiagnostictesting,informationandservices,announce...ayHealthcareConferenceinNewYorkCity.Thepresentatio...asternTime. ,, Duringtheconference,thecompanywi...mate3%,operatingincometoexceed18%ofrevenues,anddil...
(Date:11/24/2009)...AKE,N.J.andNEWYORK,Nov.24/PRNewswire/-- EisaiInc....ministration(FDA)hasacceptedforreviewEisai,sNewDru...epezilHClextendedrelease)tabletsforthetreatmentofm...rdoseformulationcontains23mgofdonepezilHClinanexte...atallowsforgradualreleaseofthedrug.TheNDAisbasedon...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Soyfoods a Healthy Choice for Men 48575 1Soyfoods a Healthy Choice for Men 48575 2Soyfoods a Healthy Choice for Men 48575 3Soyfoods a Healthy Choice for Men 48575 4Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Review Period for Intermezzo 28R 29 48570 1Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Review Period for Intermezzo 28R 29 48570 2Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Review Period for Intermezzo 28R 29 48570 3Transcept Pharmaceuticals Announces Expected FDA Extension of Regulatory Review Period for Intermezzo 28R 29 48570 4Haemacure Reports on Strategic Collaboration with Angiotech Pharmaceuticals Inc and Second Quarter 2009 Financial Results 48565 1Haemacure Reports on Strategic Collaboration with Angiotech Pharmaceuticals Inc and Second Quarter 2009 Financial Results 48565 2Haemacure Reports on Strategic Collaboration with Angiotech Pharmaceuticals Inc and Second Quarter 2009 Financial Results 48565 3Haemacure Reports on Strategic Collaboration with Angiotech Pharmaceuticals Inc and Second Quarter 2009 Financial Results 48565 4
...il 16 Simbionix, the world,s leading,developer of...reement with,Johnson & Johnson LLC for distrib...ts. , Johnson & Johnson, LLC operates in R... subsidiaries of Johnson & Johnson. , John...o distribute,Simbionix,s line of advanced medical ...
...The following letter is being released by CEL-SCI ...s: , , Dear Fellow Shareholders: , , A very imp... Dendreon Corporation has announced that its pivot...et its primary endpoint of improving overall survi...from the 512 patient study will be presented on Ap...
Other Medicine Technology:Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries 2CEL-SCI Corporation Releases Letter to Shareholders 2CEL-SCI Corporation Releases Letter to Shareholders 3
VascoStim 2/5F S
Aescula LV Left-Heart Lead
HT-PB
CapSure Novus
Medicine Products: